标题
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
作者
关键词
-
出版物
Journal of Cardiovascular Translational Research
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-29
DOI
10.1007/s12265-020-09994-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
- (2019) Thomas S. G. Sehested et al. JAMA Cardiology
- Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
- (2019) Alexander Peikert et al. Clinical Research in Cardiology
- Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
- (2019) Ingrid Gergei et al. ATHEROSCLEROSIS
- Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease
- (2019) Cheryl S Sultan et al. CARDIOVASCULAR RESEARCH
- rs1883832: a CD40 single-nucleotide polymorphism for predicting coronary heart disease in humans
- (2019) Esther Lutgens CARDIOVASCULAR RESEARCH
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE−/− mice
- (2019) Miguel Hueso et al. Journal of Inflammation-London
- Distinct CD40L receptors mediate inflammasome activation and secretion of IL-1β and MCP-1 in cultured human retinal pigment epithelial cells
- (2018) Zong-Mei Bian et al. EXPERIMENTAL EYE RESEARCH
- Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis
- (2018) Tom T.P. Seijkens et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell–platelet–monocyte interaction
- (2018) Miruna Popa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense
- (2018) Dennis Wolf et al. Nature Communications
- Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
- (2018) Marnix Lameijer et al. Nature Biomedical Engineering
- Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
- (2018) Jodi L. Karnell et al. ADVANCED DRUG DELIVERY REVIEWS
- The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management
- (2018) Reza Yazdani et al. CLINICAL IMMUNOLOGY
- Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure
- (2018) Lena Bosch et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation
- (2018) Rachel A. Woolaver et al. JOURNAL OF IMMUNOLOGY
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and LeukocytesSignificance
- (2016) Norbert Gerdes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis
- (2016) Miguel Hueso et al. ATHEROSCLEROSIS
- Soluble CD40 Ligand Promotes Macrophage Foam Cell Formation in the Etiology of Atherosclerosis
- (2015) Ming Yuan et al. CARDIOLOGY
- Blocking α5β1 Integrin Attenuates sCD40L-Mediated Platelet Activation
- (2015) Damir Simic et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Discovery of Small Molecule CD40–TRAF6 Inhibitors
- (2015) Barbara Zarzycka et al. Journal of Chemical Information and Modeling
- Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand
- (2015) Vanessa Valdes et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells
- (2015) Kerstin Möller et al. THROMBOSIS AND HAEMOSTASIS
- CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation
- (2015) Aaron J Donner et al. Molecular Therapy-Nucleic Acids
- Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
- (2014) Hamdi Pusuroglu et al. CORONARY ARTERY DISEASE
- Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice
- (2014) S M van den Berg et al. INTERNATIONAL JOURNAL OF OBESITY
- The SNP rs1883832 in CD40 Gene and Risk of Atherosclerosis in Chinese Population: A Meta-Analysis
- (2014) Yan Yun et al. PLoS One
- Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
- (2014) A. Chatzigeorgiou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble CD40 Ligand Stimulates the Pro-Angiogenic Function of Peripheral Blood Angiogenic Outgrowth Cells via Increased Release of Matrix Metalloproteinase-9
- (2013) Lara Bou Khzam et al. PLoS One
- Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species
- (2013) Lara Khzam et al. THROMBOSIS AND HAEMOSTASIS
- CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
- (2012) Tom Seijkens et al. Diabetes & Vascular Disease Research
- Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes
- (2012) A. Arranz et al. JOURNAL OF CONTROLLED RELEASE
- Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice
- (2011) Dennis Wolf et al. CIRCULATION RESEARCH
- A comparative study of biomarkers for risk prediction in acute coronary syndrome—Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study
- (2010) Juan Carlos Kaski et al. ATHEROSCLEROSIS
- A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome
- (2010) Caixia Tian et al. BIOMEDICINE & PHARMACOTHERAPY
- The CD40 Gene Polymorphism rs1883832 Is Associated with Risk of Acute Coronary Syndrome in a Chinese Case–Control Study
- (2010) Ming Wang et al. DNA AND CELL BIOLOGY
- Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome
- (2010) Budi Y. Setianto et al. HEART AND VESSELS
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
- (2010) Esther Lutgens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/α5β1 interaction
- (2010) Lionel Loubaki et al. MOLECULAR IMMUNOLOGY
- HSP 70 and atherosclerosis – protector or activator?
- (2009) Agata Bielecka-Dabrowa et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis
- (2009) David Engel et al. SEMINARS IN IMMUNOLOGY
- Systemic blood coagulation activation in acute coronary syndromes
- (2008) A. Undas et al. BLOOD
- The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling
- (2008) M. M. P. C. Donners et al. BLOOD
- Clinical Implications of Elevated Serum Interleukin-6, Soluble CD40 Ligand, Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Acute ST-segment Elevation Myocardial Infarction
- (2008) Jing Tan et al. CLINICAL CARDIOLOGY
- Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation
- (2008) Alberto Dominguez-Rodriguez et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search